Managers / Q2 2021 · view latest →
Birch Grove Capital LP
CIK 0001652355 · 590 MADISON AVENUE, 38TH FLOOR, NEW YORK, NY, 10022 · 212-753-7510
Summary
Birch Grove Capital LP reported $206M in U.S.-listed holdings across 46 positions for Q2 2021.
Its largest position, Kaman, represents 9.7% of the portfolio.
Compared with Q1 2021, the fund opened 11 new positions and exited 15.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- US DOMESTIC · 67.0% · $138M
- Common Stock · 15.9% · $33M
- Other · 8.0% · $17M
- PRIV PLACEMENT · 6.0% · $12M
- GLOBAL · 2.6% · $5M
- ETP · 0.5% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SPLUNK INC | NEW | +11.05M | 11.05M | +$11M | $11M |
| TELADOC HEALTH INC | NEW | +4.00M | 4.00M | +$4M | $4M |
| CHURCHILL CAPITAL CORP V | NEW | +400.0K | 400.0K | +$4M | $4M |
| 8X8 INC NEW | NEW | +2.50M | 2.50M | +$3M | $3M |
| SPIRIT AEROSYSTEMS HLDGS INC | NEW | +45.1K | 45.1K | +$2M | $2M |
| FLEXION THERAPEUTICS INC | NEW | +62.0K | 62.0K | +$510,000 | $510,000 |
| QQQINVESCO QQQ TR | NEW | +90.3K | 90.3K | +$334,000 | $334,000 |
| CHURCHILL CAPITAL CORP V | NEW | +100.0K | 100.0K | +$206,000 | $206,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | KAMAN CORP | NOTE 3.250% 5/0 | 9.73% | $20M | 18.83M |
| 2 | FLEXION THERAPEUTICS INC | NOTE 3.375% 5/0 · COM | 9.08% | $19M | 20.21M |
| 3 | SPLUNK INC | NOTE 1.125% 6/1 · NOTE 1.125% 9/1 | 8.75% | $18M | 17.05M |
| 4 | JAZZ INVESTMENTS I LTD | NOTE 1.500% 8/1 | 8.62% | $18M | 16.10M |
| 5 | LIBERTY MEDIA CORP DEL | NOTE 1.000% 1/3 · DEB 2.250% 9/3 | 6.83% | $14M | 12.86M |
| 6 | INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 6.56% | $14M | 15.00M |
| 7 | HERBALIFE LTD | NOTE 2.625% 3/1 | 5.49% | $11M | 10.36M |
| 8 | TABULA RASA HEALTHCARE INC | NOTE 1.750% 2/1 | 3.73% | $8M | 7.50M |
| 9 | RADIUS HEALTH INC | NOTE 3.000% 9/0 · COM NEW | 3.58% | $7M | 6.57M |
| 10 | APOLLO COML REAL EST FIN INC | NOTE 4.750% 8/2 · NOTE 5.375% 10/1 | 3.43% | $7M | 7.00M |
| 11 | BLACKSTONE MTG TR INC | NOTE 4.375% 5/0 | 2.82% | $6M | 5.70M |
| 12 | EVOLENT HEALTH INC | NOTE 1.500% 10/1 | 2.58% | $5M | 5.50M |
| 13 | TELADOC HEALTH INC | NOTE 1.250% 6/0 | 2.18% | $4M | 4.00M |
| 14 | CHURCHILL CAPITAL CORP V | COM CL A · *W EXP 10/29/202 | 2.06% | $4M | 500.0K |
| 15 | CHURCHILL CAPITAL CORP VI | UNIT 99/99/9999 | 1.97% | $4M | 400.0K |
| 16 | CHURCHILL CAPITAL CORP VII | UNIT 99/99/9999 | 1.95% | $4M | 400.0K |
| 17 | NMRKNEWMARK GROUP INChistory → | CL A | 1.78% | $4M | 304.6K |
| 18 | GOHEALTH INC | COM CL A | 1.70% | $4M | 312.7K |
| 19 | NUTANIX INC | NOTE 1/1 | 1.54% | $3M | 3.00M |
| 20 | BCOBRINKS COhistory → | COM | 1.54% | $3M | 41.3K |
| 21 | 8X8 INC NEW | NOTE 0.500% 2/0 | 1.51% | $3M | 2.50M |
| 22 | BMRNBIOMARIN PHARMACEUTICAL INChistory → | COM | 1.43% | $3M | 35.4K |
| 23 | DISDISNEY WALT COhistory → | COM | 1.34% | $3M | 15.7K |
| 24 | OIO-I GLASS INChistory → | COM | 1.33% | $3M | 168.1K |
| 25 | WSCWILLSCOT MOBIL MINI HLDNG COhistory → | COM CL A | 1.33% | $3M | 98.0K |
| 26 | SLQTSELECTQUOTE INChistory → | COM | 1.20% | $2M | 128.2K |
| 27 | MULTIPLAN CORPORATION | COM · *W EXP 02/13/202 | 1.16% | $2M | 306.9K |
| 28 | LVSLAS VEGAS SANDS CORPhistory → | COM | 1.04% | $2M | 40.8K |
| 29 | SPIRIT AEROSYSTEMS HLDGS INC | COM CL A | 1.03% | $2M | 45.1K |
| 30 | DHTDHT HOLDINGS INC | SHS NEW | 0.97% | $2M | 307.4K |
| 31 | HOWARD HUGHES CORP | COM | 0.82% | $2M | 17.4K |
| 32 | EHTHEHEALTH INC | COM | 0.28% | $569,000 | 9.7K |
| 33 | SKILLSOFT CORP | *W EXP 06/11/202 | 0.04% | $84,000 | 33.3K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $10M | 3 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $10M | 4 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $13M | 6 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $23M | 9 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $57M | 12 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $68M | 13 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023REVEALED | $110M | 20 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $202M | 33 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $256M | 41 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $252M | 41 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $245M | 38 | May 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $221M | 47 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $212M | 52 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $206M | 46 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $230M | 50 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $192M | 40 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $185M | 46 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $121M | 43 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $70M | 13 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $81M | 16 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $135M | 29 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $131M | 13 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $166M | 23 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $222M | 28 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.